This finding represents a characteristic feature shared by the three major thrombocytopenia-related disorders associated with an increased risk of hematologic malignancy—RUNX1-, ETV6-, and ANKRD26-related thrombocytopenia. This evidence concerns the gene ANKRD26 and Thrombocytopenia.